Liu TC - Search Results

1

Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib.

Wu KL, Tsai MJ, Yang CJ, Chang WA, Hung JY, Yen CJ, Shen CH, Kuo TY, Lee JY, Chou SH, Liu TC, Chong IW, Huang MS. Wu KL, et al. Among authors: liu tc. Lung Cancer. 2015 May;88(2):187-94. doi: 10.1016/j.lungcan.2015.02.012. Epub 2015 Feb 23. Lung Cancer. 2015. PMID: 25747806

2

{beta}-thalassemia major evolution from {beta}-thalassemia minor is associated with paternal uniparental isodisomy of chromosome 11p15.

Chang JG, Tsai WC, Chong IW, Chang CS, Lin CC, Liu TC. Chang JG, et al. Among authors: liu tc. Haematologica. 2008 Jun;93(6):913-6. doi: 10.3324/haematol.12195. Epub 2008 Apr 15. Haematologica. 2008. PMID: 18413893 Free article.

3

Correlation between EGFR mutation status and computed tomography features in patients with advanced pulmonary adenocarcinoma.

Hsu JS, Huang MS, Chen CY, Liu GC, Liu TC, Chong IW, Chou SH, Yang CJ. Hsu JS, et al. Among authors: liu gc, liu tc. J Thorac Imaging. 2014 Nov;29(6):357-63. doi: 10.1097/RTI.0000000000000116. J Thorac Imaging. 2014. PMID: 25303964

4

Increase EGFR Mutations Detection Rate in Lung Adenocarcinoma by Real-Time PCR Screening Followed by Direct Sequencing.

Er TK, Lin CW, Liu TC, Chen CC, Wang LH, Hsieh LL, Tsai WC. Er TK, et al. Among authors: liu tc. Appl Immunohistochem Mol Morphol. 2015 May-Jun;23(5):343-8. doi: 10.1097/PDM.0000000000000037. Appl Immunohistochem Mol Morphol. 2015. PMID: 25961746

5

Poorer prognosis in Taiwanese female ever smokers with stage IV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor.

Yang CJ, Tsai MJ, Hung JY, Tsai YM, Lee JY, Chou SH, Liu TC, Shen MC, Huang MS, Chong IW. Yang CJ, et al. Among authors: liu tc. Onco Targets Ther. 2016 Mar 15;9:1511-8. doi: 10.2147/OTT.S100169. eCollection 2016. Onco Targets Ther. 2016. PMID: 27042119 Free PMC article.

6

Pemetrexed had significantly better clinical efficacy in patients with stage IV lung adenocarcinoma with susceptible EGFR mutations receiving platinum-based chemotherapy after developing resistance to the first-line gefitinib treatment.

Yang CJ, Tsai MJ, Hung JY, Liu TC, Chou SH, Lee JY, Hsu JS, Tsai YM, Huang MS, Chong IW. Yang CJ, et al. Among authors: liu tc. Onco Targets Ther. 2016 Mar 16;9:1579-87. doi: 10.2147/OTT.S100164. eCollection 2016. Onco Targets Ther. 2016. PMID: 27051298 Free PMC article.

7

The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second-line cytotoxic chemotherapy.

Yang CJ, Hung JY, Tsai MJ, Wu KL, Liu TC, Chou SH, Lee JY, Hsu JS, Huang MS, Chong IW. Yang CJ, et al. Among authors: liu tc. BMC Pharmacol Toxicol. 2017 May 10;18(1):21. doi: 10.1186/s40360-017-0130-0. BMC Pharmacol Toxicol. 2017. PMID: 28486985 Free PMC article.

8

The clinical efficacy of Afatinib 30 mg daily as starting dose may not be inferior to Afatinib 40 mg daily in patients with stage IV lung Adenocarcinoma harboring exon 19 or exon 21 mutations.

Yang CJ, Tsai MJ, Hung JY, Lee MH, Tsai YM, Tsai YC, Hsu JF, Liu TC, Huang MS, Chong IW. Yang CJ, et al. Among authors: liu tc. BMC Pharmacol Toxicol. 2017 Dec 13;18(1):82. doi: 10.1186/s40360-017-0190-1. BMC Pharmacol Toxicol. 2017. PMID: 29237484 Free PMC article.

9

Validation of EGFL6 expression as a prognostic marker in patients with lung adenocarcinoma in Taiwan: a retrospective study.

Chang CC, Sung WW, Hsu HT, Yeh CM, Lee CH, Chen YL, Liu TC, Yeh KT. Chang CC, et al. Among authors: liu tc. BMJ Open. 2018 Jun 22;8(6):e021385. doi: 10.1136/bmjopen-2017-021385. BMJ Open. 2018. PMID: 29934389 Free PMC article.

10

Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors.

Tsai MJ, Hung JY, Lee MH, Kuo CY, Tsai YC, Tsai YM, Liu TC, Yang CJ, Huang MS, Chong IW. Tsai MJ, et al. Among authors: liu tc. Cancers (Basel). 2018 Nov 13;10(11):434. doi: 10.3390/cancers10110434. Cancers (Basel). 2018. PMID: 30428509 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

864 results

Search Page